ARCHIVES

FDA Promises No More IND Disruptions Without “Very Valid Reasons,” Nears Agreement With NCI

This article is from The Cancer Letter archive.

Vol. 03 No. 15 | April 15, 1977

Download PDF Visit The Full Archive

Related Articles

Interview with FDA’s Richard Pazdur

October 30, 2009

FDA Issues Final Rules On Patient Access To Investigational Drugs

September 11, 2009

Appropriators Ask What Happens After NIH Budget-Doubling Ends In FY2004.

May 25, 2001

Was Dr. Bunn Insensitive Or Just Efficient? FDA Imbroglio Points To Larger Problems

November 10, 1995

French Scientists Win Nobel Prize For Discovery of HIV; German Scientist Wins For HPV Discovery As Cause Of Cervical Cancer.

October 10, 2008

IOM: No Negligence In FIAU Clinical Trial That Killed Five

March 31, 1995